Oncological disease
Conditions
Interventions
Group 1: Qualitative analysis of all female outpatients with a cancer diagnosis who received neurotoxic chemotherapy and participated in a feasibility study involving external application of rosemary
Sponsors
ARCIM Institute
Eligibility
Sex/Gender
Female
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: - Oncological disease - written informed consent for participation in the feasibility study - written informed consent for participation in the substudy
Exclusion criteria
Exclusion criteria: - Premature discontinuation of the rosemary oil intervention (less than 24 weeks) in a participant of the feasibility study - chemotherapy-induced toxicities requiring a long-term (>3 weeks) discontinuation of rosemary oil in participants of the feasibility study - irregular and sporadic use of rosemary oil
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Summary of patient statements on subjective changes in symptoms, particularly with regard to sensitivity, pain and thermal perception in the hands and feet when using rosemary oil rubs as part of a feasibility study over 24 weeks. | — |
Secondary
| Measure | Time frame |
|---|---|
| Summary of patient statements on experiences with rosemary oil rubs with regard to application, comparison with other interventions, sensory and emotional perception, practicability and suitability for everyday use, unexpected effects, sustainability and acceptance. | — |
Countries
Germany
Contacts
Public ContactJan Vagedes
ARCIM Institute
Outcome results
None listed